Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | JAK2 | O60674 | 3/20 | 0.46 |
| ▸ | TYK2 | P29597 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | JAK1 | P23458 | 2/20 | 0.46 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | NAMPT | P43490 | 3/20 | 0.42 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2792665 | 0.85 | ROCK2 (0.61) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 | |
| SCHEMBL2794581 | 0.84 | ROCK2 (0.55) | ROCK2ROCK1SMN1; SMN2HTTKDM4E | |
| SCHEMBL2793411 | 0.84 | ROCK2 (0.57) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 | |
| SCHEMBL2790117 | 0.84 | ROCK2 (0.52) | ROCK2ROCK1SMN1; SMN2KDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL2792561 | 0.83 | ROCK2 (0.53) | ROCK2ROCK1SMN1; SMN2KDM4EL3MBTL1 | |
| SCHEMBL2791263 | 0.82 | ROCK2 (0.64) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 | |
| SCHEMBL2791413 | 0.81 | ROCK2 (0.49) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 | |
| SCHEMBL2792510 | 0.81 | ROCK2 (0.49) | ROCK2ROCK1KDM4EL3MBTL1RAB9A | |
| SCHEMBL2796020 | 0.81 | ROCK2 (0.54) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 | |
| SCHEMBL2793087 | 0.81 | ROCK2 (0.54) | ROCK2ROCK1SMN1; SMN2JAK2TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100168102-A9 | Amide Derivatives as Kinase Inhibitors | DEVGEN NV (BE) | 2010-07-01 | — | — | US | disclosed |
| US-20090118283-A1 | Amide Derivatives as Kinase Inhibitors | DEVGEN NV (BE) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168102-A9 | Amide Derivatives as Kinase Inhibitors | MAP3K1, CDK1, CDK2 | DNMT3B 4282/4885ROCK2 528/4885ROCK1 414/4885 |
| US-20090118283-A1 | Amide Derivatives as Kinase Inhibitors | MAP3K1, CDK1, CDK2 | DNMT3B 4282/4885ROCK2 528/4885ROCK1 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.